GSA Capital Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

GSA Capital Partners’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-64,720	Closed	-$1.13M	–	1663
2020 Q4	$1.13M	Buy	64,720 +25,911	+67%	+$363K	0.18%	105
2020 Q3	$454K	Buy	+38,809	New	+$515K	0.08%	455
2019 Q3	–	Sell	-12,591	Closed	-$173K	–	1850
2019 Q2	$173K	Buy	+12,591	New	+$193K	0.02%	1273

GSA Capital Partners's OXFD Position: Q1 2021 in Review

GSA Capital Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 64,720 shares — an estimated $1.13M sold.

GSA Capital Partners first reported a position in OXFD in Q2 2019 and held it in 3 quarters. The position peaked at $1.13M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

GSA Capital Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
GSA Capital Partners sold 64,720 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.13M.
GSA Capital Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 3 quarters.
GSA Capital Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.13M in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on GSA Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.